The #SBIR/#STTR #NIH, #CDC, and #FDA solicitation open

  • June 30th, 2022

The 2019 #SBIR and #STTR Omnibus/Parent #Grant Solicitations for the #NIH, #CDC, and #FDA was recently released. Wondering what they will fund?

Be sure to pay close attention to the slight differences between #NIH, #CDC, #FDA, and between #SBIR and #STTR, as well as “clinical trial allowed” or “not allowed”. Each has specific requirements that are unique to the solicitation line. Need help determining whether you are doing a clinical trial?

Please note that all proposals are due by 5:00 PM local time of applicant organization on September 5 for Cycle I, January 5 for Cycle II, and April 5 for Cycle III.

Approved 2019 Program Descriptions and Research Topics Documents are here (PDF 2.31 MB) (MS WORD 614 KB), be sure that what you are proposing fits within the approved topics list.

  • #NIH, #CDC, and #FDA’s #SBIR (PA-19-272) – clinical trials are NOT ALLOWED and will accept the following application types:
    • New (Phase I, Fast-Track (NIH-only)),
    • New (SBIR Direct Phase II – NIH Only),
    • Renewal (Phase II),
    • Resubmission (all phases),
    • Renewal (Phase IIB)
  • #NIH, #CDC, and #FDA’s #STTR (PA-19-270) – clinical trials are NOT ALLOWED and will accept the following application types:
    • New (Phase I, Fast-Track)
    • Renewal (Phase II* Direct Phase II NOT allowed)
    • Resubmission (all phases)
    • Renewal (Phase IIB)
    • Revision
  • #NIH, #CDC, and #FDA’s #SBIR (PA-19-273) – clinical trials ARE ALLOWED and will accept the following application types:
    • New (Phase I, Fast-Track (NIH-only))
    • New (SBIR Direct Phase II – NIH Only)
    • Renewal (Phase II)
    • Resubmission (all phases)
    • Renewal (Phase IIB)
    • Revision
  • #NIH, #CDC, and #FDA’s #STTR (PA-19-271) – clinical trials ARE ALLOWED and will accept the following application types:
    • New (Phase I, Fast-Track)
    • Renewal (Phase II* Direct Phase II NOT allowed)
    • Resubmission (all phases)
    • Renewal (Phase IIB)
    • Revision

We help high-growth startups find and apply for non-dilutive funding. Schedule a consult call with us HERE.

error: Alert: This is protected content and belongs to E.B. Howard Consulting.